Loading... Please wait...

Our Newsletter


Magnus MR (Morphine Sulphate) 30mg by AGP x 10 Capsules

  • Magnus MR
  • Morphine Sulphate
Price:
$54.95
Weight:
5.33 Grams
Shipping:
Calculated at checkout
Bookmark and Share


Product Description

Morphine Sulphate MAGNUS MR 30 MG CAPSULES 

Therapeutic Class:Narcotic analgesic

Composition:Magnus MR 10 mg capsule, containing morphine sulphate 10 mg Magnus MR 30 mg capsule, containing morphine sulphate 30 mg

Uses

This medication is used to help relieve severe ongoing pain (such as due to cancer). Morphine belongs to a class of drugs known as opioid (narcotic) analgesics. It works in the brain to change how your body feels and responds to pain.

The higher strengths of this drug (100 milligrams or more per tablet) should be used only if you have been regularly taking moderate to large amounts of opioid pain medications. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids.

Do not use the extended-release form of morphine to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use.

Description:Morphine applies an agonist effect at saturable opioid receptors in the CNS and other tissues & acts as opioid analgesic. Morphine is an analgesic drug used to treat acute and chronic pain. Obesity is frequently associated with pain of various origins (e.g. arthritis, fibromyalgia, cancer), which increases the need for analgesic drugs. Obesity changes drug pharmacokinetics, and for certain drugs, specific modalities of prescription have been proposed for obese patients. However, scant data are available regarding the pharmacokinetics and pharmacodynamics of morphine in obesity. Prescription of morphine depends on pain relief but the occurrence of respiratory adverse effects correlates with obesity, and is not currently taken into account. Variations in the volume of distribution, elimination half-life and oral clearance of morphine, as well as recent advances in the respective roles of drug-metabolizing enzymes, catechol-O-methyltransferase and the μ opioid receptor in morphine pharmacokinetics and pharmacodynamics, may contribute to differences between obese and non-obese patients. In addition, drug-drug interactions may alter the disposition of morphine and its glucuronide metabolites, which may either increase the risk of adverse effects or reduce drug efficacy.

Indications:Severe chronic pain or pain resistant to other analgesics, in particular pain associated with cancer.

Dosage:Adults:Recommended dosage is one capsule twice daily, at 12-hour intervals.Elderly:As with all narcotics a reduction in dosage may be advisable in the elderly, as appropriate.